A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care DOI
Megan E. Miller,

Mark Meyers,

A. Martín

et al.

Journal of Hospice and Palliative Nursing, Journal Year: 2024, Volume and Issue: 27(2), P. 67 - 73

Published: Dec. 19, 2024

Psychedelic-assisted therapy (PAT) involves supported experiences with psychedelic medicines in carefully curated environments. Early evidence suggests possible utility of PAT for addressing psychosocial-spiritual-existential concerns, yet gaps remain understanding findings related to PAT's role palliative care. This rapid review aims synthesize current literature on applications the context Through a systematic process, we identified 34 articles published between January 2021 and July 2024. Protocols varied included common components participant screening, preparation, dosing, integration. Psilocybin was most commonly studied compound. Results support safety initial efficacy psycho-spiritual-existential outcomes among screened highly homogonous samples patients serious illness (predominantly cancer). Current efforts challenges around integrating into systems care were highlighted. Additional work is needed (1) explore within more diverse contexts, (2) train providers PAT, (3) determine delivery best suited translation practice, (4) begin developing policy solutions safe equitable access PAT. Because many lack basic care, careful consideration integration The substances which are topic this article not currently FDA approved use United States.

Language: Английский

Opinion Mining of Erowid’s Experience Reports on LSD and Psilocybin-Containing Mushrooms DOI
Ahmed Al-Imam, Riccardo Lora, Marek Motyka

et al.

Drug Safety, Journal Year: 2025, Volume and Issue: unknown

Published: March 4, 2025

Language: Английский

Citations

0
A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care DOI
Megan E. Miller,

Mark Meyers,

A. Martín

et al.

Journal of Hospice and Palliative Nursing, Journal Year: 2024, Volume and Issue: 27(2), P. 67 - 73

Published: Dec. 19, 2024

Psychedelic-assisted therapy (PAT) involves supported experiences with psychedelic medicines in carefully curated environments. Early evidence suggests possible utility of PAT for addressing psychosocial-spiritual-existential concerns, yet gaps remain understanding findings related to PAT's role palliative care. This rapid review aims synthesize current literature on applications the context Through a systematic process, we identified 34 articles published between January 2021 and July 2024. Protocols varied included common components participant screening, preparation, dosing, integration. Psilocybin was most commonly studied compound. Results support safety initial efficacy psycho-spiritual-existential outcomes among screened highly homogonous samples patients serious illness (predominantly cancer). Current efforts challenges around integrating into systems care were highlighted. Additional work is needed (1) explore within more diverse contexts, (2) train providers PAT, (3) determine delivery best suited translation practice, (4) begin developing policy solutions safe equitable access PAT. Because many lack basic care, careful consideration integration The substances which are topic this article not currently FDA approved use United States.

Language: Английский

Citations

0